Abstract:Spinal cord injury (SCI),which lead to sensory and motor function impairment,refers to traumatic injury to the spinal cord.The main pathophysiological changing process can be divided into two phases:the preliminary injury phase and the secondary injury phase.Organ dysfunction,tissue necrosis,sensory and motor function of irreversible lesions and even death can be led by SCI and the secondary injury phase.In order to prevent the secondary injury and repair the injured central nerve system,medication,surgery,biomaterials transplantation and autologous peripheral nerve transplantation have been widely studied.However,these strategies can only reach a certain level of symptoms relieve and neural restoration,which cannot reach clinical satisfaction.Therefore,SCI has been treated as a global difficult and attractive topic.Since stem cells have the potential ability to promote neurons regeneration and/or even differentiate into neural like cells,they may also have anti-inflammatory,anti-apoptotic,anti-oxidative stress,and promote secretion of trophic factors and vascularization,they brought new hope for SCI patients.Mesenchymal stem cells (MSCs) have attracted many researchers' attention for their multi characteristics including widely distribution,strong differentiation potential,easily isolating and storing and ethics avoiding.It has been proved that MSCs are effective for repairing SCI in vivo and vitro.In the latest 3 years,with the consummation of several clinical trials,a good prospect have been showed in the translation of MSCs transplantation into clinic.MSCs have been proved to have a significant prospect for clinical translation.At the same time,more specific issues were also raised.Thus,based on the latest 3 years clinical research and the author team's latest experimental results,we reviewed the MSCs on treating SCI from basic science to clinical trial and discussed its future development.

Biomaterials reinforced MSCs transplantation for spinal cord injury repair

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Biomaterial-based regenerative therapeutic strategies for spinal cord injury

Injectable hydrogel embedded with mesenchymal stem cells repairs severe spinal cord injury

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Mesenchymal Stem Cells Transplantation to Treat Spinal Cord Injury: from Basic Science to Clinical Trial

The Application of Biomaterials in Spinal Cord Injury

Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects

Multiple strategies enhance the efficacy of MSCs transplantation for spinal cord injury

Exosomes combined with biomaterials in the treatment of spinal cord injury

Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives

An integrated long-acting implant of clinical safe cells, drug and biomaterials effectively promotes spinal cord repair and restores motor functions

Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy

The Application of Biomaterial‐Based Spinal Cord Tissue Engineering

Current multi-scale biomaterials for tissue regeneration following spinal cord injury

Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury

Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells

Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges

Cell Transplantation Therapies for Spinal Cord Injury Focusing on Bone Marrow Mesenchymal Stem Cells: Advances and Challenges